0001209191-19-049420.txt : 20190913
0001209191-19-049420.hdr.sgml : 20190913
20190913122624
ACCESSION NUMBER: 0001209191-19-049420
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190912
FILED AS OF DATE: 20190913
DATE AS OF CHANGE: 20190913
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Wilson Jason Douglas
CENTRAL INDEX KEY: 0001662395
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37785
FILM NUMBER: 191092032
MAIL ADDRESS:
STREET 1: C/O REATA PHARMACEUTICALS, INC.
STREET 2: 2801 GATEWAY DR. SUITE 150
CITY: IRVING
STATE: TX
ZIP: 75063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: REATA PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001358762
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 113651945
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2801 GATEWAY DRIVE SUITE 150
CITY: IRVING
STATE: TX
ZIP: 75063
BUSINESS PHONE: 972-865-2206
MAIL ADDRESS:
STREET 1: 2801 GATEWAY DRIVE SUITE 150
CITY: IRVING
STATE: TX
ZIP: 75063
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2019-09-12
0
0001358762
REATA PHARMACEUTICALS INC
RETA
0001662395
Wilson Jason Douglas
2801 GATEWAY DRIVE
SUITE 150
IRVING
TX
75063
0
1
0
0
Executive VP of Operations
Employee Stock Option (right to buy)
11.62
2019-09-12
4
M
0
7350
0.00
D
2023-06-15
Class B common stock
7350
13881
D
Class B common stock
2019-09-12
4
M
0
7350
11.62
A
Class A common stock
7350
50996
D
The options vested in twenty equal quarterly installments beginning on September 15, 2013.
The Class B common stock is convertible into Class A common stock on a one-for-one basis at the holder's election at any time. The conversion right of the Class B common stock has no expiration date.
/s/ Michael D. Wortley, attorney-in-fact
2019-09-13